PMID- 7525714 OWN - NLM STAT- MEDLINE DCOM- 19941207 LR - 20071114 IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 153 IP - 10 DP - 1994 Nov 15 TI - Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. PG - 4733-41 AB - Recent studies indicate that monocyte chemoattractant protein-1 (MCP-1) may play an important role in pulmonary inflammation. In vitro studies show that a number of cell types are capable of producing MCP-1. In this study, MCP-1 expression in lungs of rats with bleomycin (BLM)-induced pulmonary fibrosis is examined to evaluate its cellular origin and potential role in pathogenesis. Lung fibrosis was induced in male Fisher 344 rats by endotracheal injection on day 0. On selected days after injection, lungs were harvested for in situ and Northern hybridization analyses for MCP-1 mRNA expression, immunochemical and histochemical analyses for MCP-1 protein expression, and identification of cell type. Northern analysis revealed significant elevation in lung MCP-1 mRNA expression beginning on day 3 post-BLM treatment, increasing to a peak on day 7, and then decreasing toward control levels after day 21. In situ hybridization combined with histochemical staining with chromotrope 2R indicate that most of the cells expressing MCP-1 mRNA at these time points are primarily eosinophils. A few scattered reactive fibroblasts, some mononuclear cells, epithelial cells, and cells of certain blood vessel walls also express this mRNA. Increased MCP-1 protein expression also was found to be predominantly within and adjacent to eosinophils. The eosinophils expressing this mRNA were found predominantly within areas of active fibrosis. The kinetics of increase in the number of cells expressing significant MCP-1 mRNA in lung sections paralleled that for MCP-1 mRNA expression, as assessed by Northern analysis. These results, for the first time, demonstrate that MCP-1 is up-regulated significantly in this rat animal model, and that infiltrating eosinophils represent the major cellular source for this increased MCP-1 expression. FAU - Zhang, K AU - Zhang K AD - Department of Pathology, University of Michigan Medical School, Ann Arbor 48109. FAU - Gharaee-Kermani, M AU - Gharaee-Kermani M FAU - Jones, M L AU - Jones ML FAU - Warren, J S AU - Warren JS FAU - Phan, S H AU - Phan SH LA - eng GR - HL28737/HL/NHLBI NIH HHS/United States GR - HL31963/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Chemokine CCL2) RN - 0 (Chemotactic Factors) RN - 0 (Cytokines) RN - 11056-06-7 (Bleomycin) SB - IM MH - Animals MH - Base Sequence MH - Bleomycin MH - Blotting, Northern MH - Chemokine CCL2 MH - Chemotactic Factors/*biosynthesis MH - Cytokines/*biosynthesis MH - Gene Expression Regulation/genetics MH - Immunoenzyme Techniques MH - In Situ Hybridization MH - Lung/*immunology/pathology MH - Male MH - Molecular Sequence Data MH - Pulmonary Fibrosis/chemically induced/*immunology/pathology MH - Rats MH - Rats, Inbred F344 EDAT- 1994/11/15 00:00 MHDA- 1994/11/15 00:01 CRDT- 1994/11/15 00:00 PHST- 1994/11/15 00:00 [pubmed] PHST- 1994/11/15 00:01 [medline] PHST- 1994/11/15 00:00 [entrez] PST - ppublish SO - J Immunol. 1994 Nov 15;153(10):4733-41.